BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1776842)

  • 1. Endometrial hyperplasia following estrogen treatment without the addition of gestagen. A follow-up study after withdrawal of estrogens.
    Lindahl B; Willén R
    Anticancer Res; 1991; 11(6):2071-3. PubMed ID: 1776842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years.
    Lindahl B; Willén R
    Anticancer Res; 1994; 14(5B):2141-6. PubMed ID: 7840513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometrical DNA measurements in endometrial hyperplasias. A prospective follow-up study after abrasio only or additional high-dose gestagen treatment.
    Lindahl B; Alm P
    Anticancer Res; 1991; 11(1):391-5. PubMed ID: 1826822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous endometrial hyperplasia. A 5 year follow-up of 82 patients after high-dose gestagen treatment.
    Lindahl B; Willén R
    Anticancer Res; 1994; 14(6B):2831-4. PubMed ID: 7872726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous endometrial hyperplasia. The prognostic significance of steroid receptor concentration. A two year follow-up of patients treated with abrasio only.
    Lindahl B; Fernö M; Norgren A; Willen R
    Anticancer Res; 1991; 11(5):1875-7. PubMed ID: 1768058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial response to estrogen and progesterone therapy in patients with gonadal dysgenesis.
    Benjamin I; Block RE
    Obstet Gynecol; 1977 Aug; 50(2):136-8. PubMed ID: 876552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
    Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
    J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atypical endometrial hyperplasia. Prognosis and course].
    Jensen HH; Hussain SF; Pedersen PH; Andreasson B
    Ugeskr Laeger; 2000 Jan; 162(5):666-9. PubMed ID: 10707601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
    Ørbo A; Arnes M; Hancke C; Vereide AB; Pettersen I; Larsen K
    Gynecol Oncol; 2008 Oct; 111(1):68-73. PubMed ID: 18684496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.
    Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
    Gynecol Oncol; 2006 May; 101(2):269-73. PubMed ID: 16297970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern tendencies in treatment of atypical glandular hyperplasia--our and foreign experience].
    Ivanov S; Kovachev E; Tsonev A; Abbud A
    Akush Ginekol (Sofiia); 2010; 49(2):47-9. PubMed ID: 20734678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients.
    Lindahl B; Willén R
    Anticancer Res; 1991; 11(1):403-6. PubMed ID: 1826823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of endometrial hyperplasia: a retrospective analysis.
    Triwitayakorn A; Rojanasakul A
    J Med Assoc Thai; 1999 Jan; 82(1):33-9. PubMed ID: 10087736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristic of cystic glandular hyperplasia as a precursor of endometrial carcinoma].
    Yokosuka K; Teshima H; Yamakawa Y; Hasumi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1241-6. PubMed ID: 7844442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
    Vereide AB; Kaino T; Sager G; Ørbo A;
    Gynecol Oncol; 2005 Jun; 97(3):740-50. PubMed ID: 15885761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.